nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Chlorambucil—breast cancer	0.146	0.333	CiPCiCtD
Busulfan—Alkylating Activity—Thiotepa—breast cancer	0.146	0.333	CiPCiCtD
Busulfan—Alkylating Activity—Melphalan—breast cancer	0.146	0.333	CiPCiCtD
Busulfan—GSTA1—breast cancer	0.0885	0.367	CbGaD
Busulfan—GSTP1—Chlorambucil—breast cancer	0.0803	0.438	CbGbCtD
Busulfan—GSTA2—breast cancer	0.069	0.286	CbGaD
Busulfan—GSTM1—breast cancer	0.0378	0.156	CbGaD
Busulfan—GSTM1—Carboplatin—breast cancer	0.0359	0.196	CbGbCtD
Busulfan—GSTP1—breast cancer	0.035	0.145	CbGaD
Busulfan—GSTP1—Carboplatin—breast cancer	0.0259	0.141	CbGbCtD
Busulfan—CYP3A4—breast cancer	0.0113	0.0468	CbGaD
Busulfan—CYP3A4—Exemestane—breast cancer	0.00548	0.0299	CbGbCtD
Busulfan—CYP3A4—Letrozole—breast cancer	0.00466	0.0254	CbGbCtD
Busulfan—CYP3A4—Anastrozole—breast cancer	0.00415	0.0227	CbGbCtD
Busulfan—CYP3A4—Toremifene—breast cancer	0.0038	0.0207	CbGbCtD
Busulfan—CYP3A4—Fulvestrant—breast cancer	0.00353	0.0193	CbGbCtD
Busulfan—CYP3A4—Thiotepa—breast cancer	0.00315	0.0172	CbGbCtD
Busulfan—CYP3A4—Ixabepilone—breast cancer	0.00288	0.0157	CbGbCtD
Busulfan—CYP3A4—Lapatinib—breast cancer	0.00277	0.0151	CbGbCtD
Busulfan—CYP3A4—Raloxifene—breast cancer	0.0021	0.0115	CbGbCtD
Busulfan—CYP3A4—Vinorelbine—breast cancer	0.00154	0.00839	CbGbCtD
Busulfan—CYP3A4—Tamoxifen—breast cancer	0.00139	0.00757	CbGbCtD
Busulfan—CYP3A4—Mitoxantrone—breast cancer	0.00135	0.00738	CbGbCtD
Busulfan—CYP3A4—Paclitaxel—breast cancer	0.00108	0.00589	CbGbCtD
Busulfan—CYP3A4—Irinotecan—breast cancer	0.00107	0.00581	CbGbCtD
Busulfan—CYP3A4—Vinblastine—breast cancer	0.000947	0.00517	CbGbCtD
Busulfan—GSTA1—embryo—breast cancer	0.000821	0.0471	CbGeAlD
Busulfan—CYP3A4—Docetaxel—breast cancer	0.000781	0.00426	CbGbCtD
Busulfan—GSTA1—epithelium—breast cancer	0.00067	0.0385	CbGeAlD
Busulfan—MGST2—uterus—breast cancer	0.000651	0.0374	CbGeAlD
Busulfan—MGST2—adipose tissue—breast cancer	0.000637	0.0366	CbGeAlD
Busulfan—GSTA2—embryo—breast cancer	0.000593	0.034	CbGeAlD
Busulfan—MGST2—female reproductive system—breast cancer	0.000586	0.0336	CbGeAlD
Busulfan—CYP3A4—Doxorubicin—breast cancer	0.000582	0.00318	CbGbCtD
Busulfan—MGST2—Azacitidine—Gemcitabine—breast cancer	0.000577	1	CbGdCrCtD
Busulfan—MGST2—adrenal gland—breast cancer	0.000571	0.0328	CbGeAlD
Busulfan—GSTA1—uterus—breast cancer	0.000554	0.0318	CbGeAlD
Busulfan—MGST2—bone marrow—breast cancer	0.000553	0.0317	CbGeAlD
Busulfan—MGST2—female gonad—breast cancer	0.000533	0.0306	CbGeAlD
Busulfan—GSTA1—female reproductive system—breast cancer	0.000498	0.0286	CbGeAlD
Busulfan—MGST2—endocrine gland—breast cancer	0.000496	0.0284	CbGeAlD
Busulfan—GSTA1—adrenal gland—breast cancer	0.000486	0.0279	CbGeAlD
Busulfan—GSTA2—epithelium—breast cancer	0.000484	0.0278	CbGeAlD
Busulfan—GSTM1—skin of body—breast cancer	0.000472	0.0271	CbGeAlD
Busulfan—GSTP1—nipple—breast cancer	0.000461	0.0265	CbGeAlD
Busulfan—GSTA1—female gonad—breast cancer	0.000453	0.026	CbGeAlD
Busulfan—GSTA1—endocrine gland—breast cancer	0.000421	0.0242	CbGeAlD
Busulfan—GSTM1—adipose tissue—breast cancer	0.000401	0.023	CbGeAlD
Busulfan—GSTA2—uterus—breast cancer	0.0004	0.0229	CbGeAlD
Busulfan—GSTP1—embryo—breast cancer	0.000381	0.0218	CbGeAlD
Busulfan—GSTM1—female reproductive system—breast cancer	0.000368	0.0211	CbGeAlD
Busulfan—GSTM1—adrenal gland—breast cancer	0.000359	0.0206	CbGeAlD
Busulfan—GSTA2—female reproductive system—breast cancer	0.000359	0.0206	CbGeAlD
Busulfan—GSTA2—adrenal gland—breast cancer	0.000351	0.0201	CbGeAlD
Busulfan—MGST2—lymph node—breast cancer	0.000343	0.0197	CbGeAlD
Busulfan—GSTM1—female gonad—breast cancer	0.000335	0.0192	CbGeAlD
Busulfan—GSTA2—female gonad—breast cancer	0.000327	0.0188	CbGeAlD
Busulfan—GSTM1—endocrine gland—breast cancer	0.000312	0.0179	CbGeAlD
Busulfan—GSTP1—epithelium—breast cancer	0.000311	0.0178	CbGeAlD
Busulfan—GSTA2—endocrine gland—breast cancer	0.000304	0.0175	CbGeAlD
Busulfan—GSTP1—skin of body—breast cancer	0.000295	0.017	CbGeAlD
Busulfan—GSTP1—endometrium—breast cancer	0.000278	0.016	CbGeAlD
Busulfan—GSTP1—uterus—breast cancer	0.000257	0.0147	CbGeAlD
Busulfan—GSTP1—pituitary gland—breast cancer	0.000252	0.0145	CbGeAlD
Busulfan—GSTP1—adipose tissue—breast cancer	0.000251	0.0144	CbGeAlD
Busulfan—GSTP1—female reproductive system—breast cancer	0.000231	0.0132	CbGeAlD
Busulfan—GSTP1—adrenal gland—breast cancer	0.000225	0.0129	CbGeAlD
Busulfan—GSTP1—bone marrow—breast cancer	0.000218	0.0125	CbGeAlD
Busulfan—GSTM1—lymph node—breast cancer	0.000215	0.0124	CbGeAlD
Busulfan—GSTP1—female gonad—breast cancer	0.00021	0.012	CbGeAlD
Busulfan—GSTP1—endocrine gland—breast cancer	0.000195	0.0112	CbGeAlD
Busulfan—GSTP1—lymph node—breast cancer	0.000135	0.00774	CbGeAlD
Busulfan—CYP3A4—female reproductive system—breast cancer	9.4e-05	0.0054	CbGeAlD
Busulfan—CYP3A4—endocrine gland—breast cancer	7.96e-05	0.00457	CbGeAlD
Busulfan—Musculoskeletal discomfort—Docetaxel—breast cancer	8.01e-06	0.000109	CcSEcCtD
Busulfan—Chills—Methotrexate—breast cancer	8e-06	0.000109	CcSEcCtD
Busulfan—Headache—Irinotecan—breast cancer	7.96e-06	0.000108	CcSEcCtD
Busulfan—Headache—Mitoxantrone—breast cancer	7.96e-06	0.000108	CcSEcCtD
Busulfan—Hypotension—Capecitabine—breast cancer	7.95e-06	0.000108	CcSEcCtD
Busulfan—Insomnia—Docetaxel—breast cancer	7.95e-06	0.000108	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—breast cancer	7.89e-06	0.000107	CcSEcCtD
Busulfan—Alopecia—Methotrexate—breast cancer	7.88e-06	0.000107	CcSEcCtD
Busulfan—Vomiting—Gemcitabine—breast cancer	7.87e-06	0.000107	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—breast cancer	7.86e-06	0.000107	CcSEcCtD
Busulfan—Dyspnoea—Docetaxel—breast cancer	7.83e-06	0.000106	CcSEcCtD
Busulfan—Somnolence—Docetaxel—breast cancer	7.81e-06	0.000106	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—breast cancer	7.81e-06	0.000106	CcSEcCtD
Busulfan—Rash—Gemcitabine—breast cancer	7.81e-06	0.000106	CcSEcCtD
Busulfan—Dermatitis—Gemcitabine—breast cancer	7.8e-06	0.000106	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—breast cancer	7.8e-06	0.000106	CcSEcCtD
Busulfan—Erythema—Methotrexate—breast cancer	7.76e-06	0.000105	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—breast cancer	7.76e-06	0.000105	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—breast cancer	7.76e-06	0.000105	CcSEcCtD
Busulfan—Headache—Gemcitabine—breast cancer	7.76e-06	0.000105	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Capecitabine—breast cancer	7.75e-06	0.000105	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—breast cancer	7.74e-06	0.000105	CcSEcCtD
Busulfan—Flushing—Epirubicin—breast cancer	7.74e-06	0.000105	CcSEcCtD
Busulfan—Vomiting—Fluorouracil—breast cancer	7.74e-06	0.000105	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—breast cancer	7.74e-06	0.000105	CcSEcCtD
Busulfan—Dyspepsia—Docetaxel—breast cancer	7.74e-06	0.000105	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—breast cancer	7.72e-06	0.000105	CcSEcCtD
Busulfan—Insomnia—Capecitabine—breast cancer	7.7e-06	0.000105	CcSEcCtD
Busulfan—Rash—Fluorouracil—breast cancer	7.68e-06	0.000104	CcSEcCtD
Busulfan—Dermatitis—Fluorouracil—breast cancer	7.67e-06	0.000104	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—breast cancer	7.66e-06	0.000104	CcSEcCtD
Busulfan—Decreased appetite—Docetaxel—breast cancer	7.64e-06	0.000104	CcSEcCtD
Busulfan—Hypersensitivity—Paclitaxel—breast cancer	7.64e-06	0.000104	CcSEcCtD
Busulfan—Headache—Fluorouracil—breast cancer	7.63e-06	0.000104	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—breast cancer	7.62e-06	0.000104	CcSEcCtD
Busulfan—Gastrointestinal disorder—Docetaxel—breast cancer	7.59e-06	0.000103	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—breast cancer	7.59e-06	0.000103	CcSEcCtD
Busulfan—Dyspnoea—Capecitabine—breast cancer	7.59e-06	0.000103	CcSEcCtD
Busulfan—Fatigue—Docetaxel—breast cancer	7.58e-06	0.000103	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—breast cancer	7.57e-06	0.000103	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—breast cancer	7.57e-06	0.000103	CcSEcCtD
Busulfan—Nausea—Mitoxantrone—breast cancer	7.55e-06	0.000103	CcSEcCtD
Busulfan—Nausea—Irinotecan—breast cancer	7.55e-06	0.000103	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—breast cancer	7.54e-06	0.000102	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—breast cancer	7.52e-06	0.000102	CcSEcCtD
Busulfan—Pain—Docetaxel—breast cancer	7.51e-06	0.000102	CcSEcCtD
Busulfan—Constipation—Docetaxel—breast cancer	7.51e-06	0.000102	CcSEcCtD
Busulfan—Back pain—Methotrexate—breast cancer	7.51e-06	0.000102	CcSEcCtD
Busulfan—Dyspepsia—Capecitabine—breast cancer	7.49e-06	0.000102	CcSEcCtD
Busulfan—Chills—Epirubicin—breast cancer	7.49e-06	0.000102	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—breast cancer	7.45e-06	0.000101	CcSEcCtD
Busulfan—Asthenia—Paclitaxel—breast cancer	7.44e-06	0.000101	CcSEcCtD
Busulfan—Decreased appetite—Capecitabine—breast cancer	7.4e-06	0.000101	CcSEcCtD
Busulfan—Alopecia—Epirubicin—breast cancer	7.37e-06	0.0001	CcSEcCtD
Busulfan—Nausea—Gemcitabine—breast cancer	7.36e-06	0.0001	CcSEcCtD
Busulfan—Gastrointestinal disorder—Capecitabine—breast cancer	7.35e-06	9.98e-05	CcSEcCtD
Busulfan—Fatigue—Capecitabine—breast cancer	7.34e-06	9.97e-05	CcSEcCtD
Busulfan—Pruritus—Paclitaxel—breast cancer	7.34e-06	9.97e-05	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—breast cancer	7.31e-06	9.93e-05	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—breast cancer	7.3e-06	9.92e-05	CcSEcCtD
Busulfan—Pain—Capecitabine—breast cancer	7.28e-06	9.89e-05	CcSEcCtD
Busulfan—Constipation—Capecitabine—breast cancer	7.28e-06	9.89e-05	CcSEcCtD
Busulfan—Erythema—Epirubicin—breast cancer	7.26e-06	9.87e-05	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—breast cancer	7.26e-06	9.87e-05	CcSEcCtD
Busulfan—Feeling abnormal—Docetaxel—breast cancer	7.24e-06	9.84e-05	CcSEcCtD
Busulfan—Nausea—Fluorouracil—breast cancer	7.23e-06	9.83e-05	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—breast cancer	7.21e-06	9.8e-05	CcSEcCtD
Busulfan—Gastrointestinal pain—Docetaxel—breast cancer	7.19e-06	9.76e-05	CcSEcCtD
Busulfan—Anaemia—Methotrexate—breast cancer	7.17e-06	9.75e-05	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—breast cancer	7.16e-06	9.74e-05	CcSEcCtD
Busulfan—Flushing—Doxorubicin—breast cancer	7.16e-06	9.74e-05	CcSEcCtD
Busulfan—Tension—Epirubicin—breast cancer	7.13e-06	9.68e-05	CcSEcCtD
Busulfan—Diarrhoea—Paclitaxel—breast cancer	7.09e-06	9.64e-05	CcSEcCtD
Busulfan—Nervousness—Epirubicin—breast cancer	7.05e-06	9.59e-05	CcSEcCtD
Busulfan—Back pain—Epirubicin—breast cancer	7.03e-06	9.55e-05	CcSEcCtD
Busulfan—Feeling abnormal—Capecitabine—breast cancer	7.01e-06	9.53e-05	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—breast cancer	7e-06	9.52e-05	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—breast cancer	6.97e-06	9.47e-05	CcSEcCtD
Busulfan—Gastrointestinal pain—Capecitabine—breast cancer	6.96e-06	9.45e-05	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—breast cancer	6.96e-06	9.45e-05	CcSEcCtD
Busulfan—Abdominal pain—Docetaxel—breast cancer	6.95e-06	9.44e-05	CcSEcCtD
Busulfan—Body temperature increased—Docetaxel—breast cancer	6.95e-06	9.44e-05	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—breast cancer	6.95e-06	9.44e-05	CcSEcCtD
Busulfan—Chills—Doxorubicin—breast cancer	6.93e-06	9.41e-05	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—breast cancer	6.9e-06	9.37e-05	CcSEcCtD
Busulfan—Dizziness—Paclitaxel—breast cancer	6.86e-06	9.32e-05	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—breast cancer	6.82e-06	9.27e-05	CcSEcCtD
Busulfan—Cough—Methotrexate—breast cancer	6.77e-06	9.2e-05	CcSEcCtD
Busulfan—Mental disorder—Doxorubicin—breast cancer	6.76e-06	9.19e-05	CcSEcCtD
Busulfan—Urticaria—Capecitabine—breast cancer	6.76e-06	9.18e-05	CcSEcCtD
Busulfan—Abdominal pain—Capecitabine—breast cancer	6.73e-06	9.14e-05	CcSEcCtD
Busulfan—Body temperature increased—Capecitabine—breast cancer	6.73e-06	9.14e-05	CcSEcCtD
Busulfan—Convulsion—Methotrexate—breast cancer	6.72e-06	9.14e-05	CcSEcCtD
Busulfan—Erythema—Doxorubicin—breast cancer	6.72e-06	9.13e-05	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—breast cancer	6.72e-06	9.13e-05	CcSEcCtD
Busulfan—Anaemia—Epirubicin—breast cancer	6.71e-06	9.12e-05	CcSEcCtD
Busulfan—Agitation—Epirubicin—breast cancer	6.67e-06	9.07e-05	CcSEcCtD
Busulfan—Chest pain—Methotrexate—breast cancer	6.61e-06	8.98e-05	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—breast cancer	6.61e-06	8.98e-05	CcSEcCtD
Busulfan—Myalgia—Methotrexate—breast cancer	6.61e-06	8.98e-05	CcSEcCtD
Busulfan—Tension—Doxorubicin—breast cancer	6.59e-06	8.96e-05	CcSEcCtD
Busulfan—Vomiting—Paclitaxel—breast cancer	6.59e-06	8.96e-05	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.56e-06	8.92e-05	CcSEcCtD
Busulfan—Rash—Paclitaxel—breast cancer	6.54e-06	8.88e-05	CcSEcCtD
Busulfan—Dermatitis—Paclitaxel—breast cancer	6.53e-06	8.87e-05	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—breast cancer	6.53e-06	8.87e-05	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—breast cancer	6.5e-06	8.83e-05	CcSEcCtD
Busulfan—Back pain—Doxorubicin—breast cancer	6.5e-06	8.83e-05	CcSEcCtD
Busulfan—Headache—Paclitaxel—breast cancer	6.49e-06	8.83e-05	CcSEcCtD
Busulfan—Hypersensitivity—Docetaxel—breast cancer	6.47e-06	8.8e-05	CcSEcCtD
Busulfan—Confusional state—Methotrexate—breast cancer	6.39e-06	8.68e-05	CcSEcCtD
Busulfan—Cough—Epirubicin—breast cancer	6.34e-06	8.61e-05	CcSEcCtD
Busulfan—Asthenia—Docetaxel—breast cancer	6.3e-06	8.57e-05	CcSEcCtD
Busulfan—Convulsion—Epirubicin—breast cancer	6.29e-06	8.55e-05	CcSEcCtD
Busulfan—Infection—Methotrexate—breast cancer	6.29e-06	8.55e-05	CcSEcCtD
Busulfan—Hypertension—Epirubicin—breast cancer	6.27e-06	8.52e-05	CcSEcCtD
Busulfan—Hypersensitivity—Capecitabine—breast cancer	6.27e-06	8.52e-05	CcSEcCtD
Busulfan—Pruritus—Docetaxel—breast cancer	6.22e-06	8.45e-05	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—breast cancer	6.21e-06	8.44e-05	CcSEcCtD
Busulfan—Anaemia—Doxorubicin—breast cancer	6.21e-06	8.44e-05	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—breast cancer	6.2e-06	8.43e-05	CcSEcCtD
Busulfan—Myalgia—Epirubicin—breast cancer	6.18e-06	8.4e-05	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—breast cancer	6.18e-06	8.4e-05	CcSEcCtD
Busulfan—Chest pain—Epirubicin—breast cancer	6.18e-06	8.4e-05	CcSEcCtD
Busulfan—Agitation—Doxorubicin—breast cancer	6.18e-06	8.39e-05	CcSEcCtD
Busulfan—Anxiety—Epirubicin—breast cancer	6.16e-06	8.37e-05	CcSEcCtD
Busulfan—Nausea—Paclitaxel—breast cancer	6.16e-06	8.37e-05	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—breast cancer	6.15e-06	8.36e-05	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.14e-06	8.34e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYP2D6—breast cancer	6.11e-06	0.000131	CbGpPWpGaD
Busulfan—Asthenia—Capecitabine—breast cancer	6.1e-06	8.3e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—SLC2A2—breast cancer	6.06e-06	0.00013	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ERCC2—breast cancer	6.06e-06	0.00013	CbGpPWpGaD
Busulfan—Dry mouth—Epirubicin—breast cancer	6.05e-06	8.22e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—NAT2—breast cancer	6.05e-06	0.00013	CbGpPWpGaD
Busulfan—Anorexia—Methotrexate—breast cancer	6.04e-06	8.2e-05	CcSEcCtD
Busulfan—Pruritus—Capecitabine—breast cancer	6.02e-06	8.18e-05	CcSEcCtD
Busulfan—Leukopenia—Doxorubicin—breast cancer	6.02e-06	8.17e-05	CcSEcCtD
Busulfan—Diarrhoea—Docetaxel—breast cancer	6.01e-06	8.17e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—NCOA2—breast cancer	5.99e-06	0.000129	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—FASN—breast cancer	5.98e-06	0.000129	CbGpPWpGaD
Busulfan—Confusional state—Epirubicin—breast cancer	5.98e-06	8.12e-05	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	5.96e-06	0.000128	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—BCHE—breast cancer	5.95e-06	0.000128	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—MTR—breast cancer	5.94e-06	0.000128	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CPT1A—breast cancer	5.94e-06	0.000128	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ABCG2—breast cancer	5.94e-06	0.000128	CbGpPWpGaD
Busulfan—Oedema—Epirubicin—breast cancer	5.93e-06	8.05e-05	CcSEcCtD
Busulfan—Hypotension—Methotrexate—breast cancer	5.92e-06	8.04e-05	CcSEcCtD
Busulfan—Infection—Epirubicin—breast cancer	5.89e-06	8e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—SLC5A5—breast cancer	5.88e-06	0.000126	CbGpPWpGaD
Busulfan—Cough—Doxorubicin—breast cancer	5.86e-06	7.97e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—HPGDS—breast cancer	5.83e-06	0.000125	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—breast cancer	5.82e-06	7.91e-05	CcSEcCtD
Busulfan—Diarrhoea—Capecitabine—breast cancer	5.82e-06	7.91e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—FASN—breast cancer	5.81e-06	0.000125	CbGpPWpGaD
Busulfan—Nervous system disorder—Epirubicin—breast cancer	5.81e-06	7.9e-05	CcSEcCtD
Busulfan—Dizziness—Docetaxel—breast cancer	5.81e-06	7.9e-05	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—breast cancer	5.8e-06	7.89e-05	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—breast cancer	5.8e-06	7.88e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—HBA1—breast cancer	5.79e-06	0.000125	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—BCHE—breast cancer	5.79e-06	0.000125	CbGpPWpGaD
Busulfan—Tachycardia—Epirubicin—breast cancer	5.78e-06	7.86e-05	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—breast cancer	5.77e-06	7.84e-05	CcSEcCtD
Busulfan—Skin disorder—Epirubicin—breast cancer	5.76e-06	7.82e-05	CcSEcCtD
Busulfan—Insomnia—Methotrexate—breast cancer	5.73e-06	7.78e-05	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—breast cancer	5.72e-06	7.77e-05	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—breast cancer	5.72e-06	7.77e-05	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—breast cancer	5.72e-06	7.77e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—SLC5A5—breast cancer	5.72e-06	0.000123	CbGpPWpGaD
Busulfan—Anxiety—Doxorubicin—breast cancer	5.7e-06	7.75e-05	CcSEcCtD
Busulfan—GSTA1—Metabolism—MTHFR—breast cancer	5.69e-06	0.000122	CbGpPWpGaD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.68e-06	7.72e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—NQO1—breast cancer	5.68e-06	0.000122	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—SLC2A1—breast cancer	5.68e-06	0.000122	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ACHE—breast cancer	5.65e-06	0.000122	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTT1—breast cancer	5.65e-06	0.000122	CbGpPWpGaD
Busulfan—Anorexia—Epirubicin—breast cancer	5.65e-06	7.68e-05	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—breast cancer	5.65e-06	7.67e-05	CcSEcCtD
Busulfan—Somnolence—Methotrexate—breast cancer	5.63e-06	7.65e-05	CcSEcCtD
Busulfan—Dizziness—Capecitabine—breast cancer	5.63e-06	7.65e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—PIK3CG—breast cancer	5.63e-06	0.000121	CbGpPWpGaD
Busulfan—Dry mouth—Doxorubicin—breast cancer	5.6e-06	7.6e-05	CcSEcCtD
Busulfan—Vomiting—Docetaxel—breast cancer	5.59e-06	7.59e-05	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—breast cancer	5.58e-06	7.58e-05	CcSEcCtD
Busulfan—Rash—Docetaxel—breast cancer	5.54e-06	7.53e-05	CcSEcCtD
Busulfan—Hypotension—Epirubicin—breast cancer	5.54e-06	7.53e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP3A4—breast cancer	5.54e-06	0.000119	CbGpPWpGaD
Busulfan—Dermatitis—Docetaxel—breast cancer	5.54e-06	7.52e-05	CcSEcCtD
Busulfan—Confusional state—Doxorubicin—breast cancer	5.53e-06	7.51e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—SLC2A1—breast cancer	5.52e-06	0.000119	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NQO1—breast cancer	5.52e-06	0.000119	CbGpPWpGaD
Busulfan—Decreased appetite—Methotrexate—breast cancer	5.51e-06	7.48e-05	CcSEcCtD
Busulfan—Headache—Docetaxel—breast cancer	5.51e-06	7.48e-05	CcSEcCtD
Busulfan—Oedema—Doxorubicin—breast cancer	5.48e-06	7.45e-05	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—breast cancer	5.47e-06	7.43e-05	CcSEcCtD
Busulfan—Fatigue—Methotrexate—breast cancer	5.46e-06	7.42e-05	CcSEcCtD
Busulfan—Infection—Doxorubicin—breast cancer	5.45e-06	7.4e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—CYP1B1—breast cancer	5.44e-06	0.000117	CbGpPWpGaD
Busulfan—Pain—Methotrexate—breast cancer	5.42e-06	7.36e-05	CcSEcCtD
Busulfan—Vomiting—Capecitabine—breast cancer	5.41e-06	7.35e-05	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—breast cancer	5.4e-06	7.34e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYP3A4—breast cancer	5.39e-06	0.000116	CbGpPWpGaD
Busulfan—Nervous system disorder—Doxorubicin—breast cancer	5.38e-06	7.31e-05	CcSEcCtD
Busulfan—Thrombocytopenia—Doxorubicin—breast cancer	5.37e-06	7.3e-05	CcSEcCtD
Busulfan—Rash—Capecitabine—breast cancer	5.36e-06	7.29e-05	CcSEcCtD
Busulfan—Insomnia—Epirubicin—breast cancer	5.36e-06	7.28e-05	CcSEcCtD
Busulfan—Dermatitis—Capecitabine—breast cancer	5.36e-06	7.28e-05	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—breast cancer	5.35e-06	7.27e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP17A1—breast cancer	5.35e-06	0.000115	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HSP90AA1—breast cancer	5.34e-06	0.000115	CbGpPWpGaD
Busulfan—Headache—Capecitabine—breast cancer	5.33e-06	7.24e-05	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	5.33e-06	0.000115	CbGpPWpGaD
Busulfan—Skin disorder—Doxorubicin—breast cancer	5.33e-06	7.24e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—ENO1—breast cancer	5.3e-06	0.000114	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS1—breast cancer	5.3e-06	0.000114	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP1B1—breast cancer	5.3e-06	0.000114	CbGpPWpGaD
Busulfan—Dyspnoea—Epirubicin—breast cancer	5.28e-06	7.18e-05	CcSEcCtD
Busulfan—Somnolence—Epirubicin—breast cancer	5.27e-06	7.16e-05	CcSEcCtD
Busulfan—GSTA1—Metabolism—CAV1—breast cancer	5.25e-06	0.000113	CbGpPWpGaD
Busulfan—Anorexia—Doxorubicin—breast cancer	5.23e-06	7.1e-05	CcSEcCtD
Busulfan—Nausea—Docetaxel—breast cancer	5.22e-06	7.09e-05	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—breast cancer	5.22e-06	7.09e-05	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—breast cancer	5.22e-06	7.09e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—NCOA1—breast cancer	5.19e-06	0.000112	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HSP90AA1—breast cancer	5.19e-06	0.000112	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP2D6—breast cancer	5.19e-06	0.000112	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Methotrexate—breast cancer	5.18e-06	7.04e-05	CcSEcCtD
Busulfan—Decreased appetite—Epirubicin—breast cancer	5.15e-06	7e-05	CcSEcCtD
Busulfan—Hypotension—Doxorubicin—breast cancer	5.12e-06	6.96e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—STK11—breast cancer	5.12e-06	0.00011	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP19A1—breast cancer	5.12e-06	0.00011	CbGpPWpGaD
Busulfan—Gastrointestinal disorder—Epirubicin—breast cancer	5.12e-06	6.95e-05	CcSEcCtD
Busulfan—Fatigue—Epirubicin—breast cancer	5.11e-06	6.94e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—NCOA2—breast cancer	5.1e-06	0.00011	CbGpPWpGaD
Busulfan—Constipation—Epirubicin—breast cancer	5.07e-06	6.89e-05	CcSEcCtD
Busulfan—Pain—Epirubicin—breast cancer	5.07e-06	6.89e-05	CcSEcCtD
Busulfan—Nausea—Capecitabine—breast cancer	5.05e-06	6.87e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—NCOA1—breast cancer	5.05e-06	0.000109	CbGpPWpGaD
Busulfan—Urticaria—Methotrexate—breast cancer	5.03e-06	6.84e-05	CcSEcCtD
Busulfan—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	5.02e-06	0.000108	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—breast cancer	5.01e-06	0.000108	CbGpPWpGaD
Busulfan—Body temperature increased—Methotrexate—breast cancer	5.01e-06	6.8e-05	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—breast cancer	5.01e-06	6.8e-05	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Doxorubicin—breast cancer	5e-06	6.79e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—STK11—breast cancer	4.98e-06	0.000107	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP19A1—breast cancer	4.98e-06	0.000107	CbGpPWpGaD
Busulfan—Insomnia—Doxorubicin—breast cancer	4.96e-06	6.74e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—PIK3CD—breast cancer	4.95e-06	0.000106	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—FASN—breast cancer	4.94e-06	0.000106	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—MTR—breast cancer	4.93e-06	0.000106	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—BCHE—breast cancer	4.92e-06	0.000106	CbGpPWpGaD
Busulfan—Dyspnoea—Doxorubicin—breast cancer	4.89e-06	6.64e-05	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—breast cancer	4.88e-06	6.64e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—ALB—breast cancer	4.88e-06	0.000105	CbGpPWpGaD
Busulfan—Somnolence—Doxorubicin—breast cancer	4.88e-06	6.63e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—SLC5A5—breast cancer	4.86e-06	0.000105	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Epirubicin—breast cancer	4.85e-06	6.59e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—HPGDS—breast cancer	4.83e-06	0.000104	CbGpPWpGaD
Busulfan—Dyspepsia—Doxorubicin—breast cancer	4.83e-06	6.56e-05	CcSEcCtD
Busulfan—GSTA1—Metabolism—PIK3CG—breast cancer	4.78e-06	0.000103	CbGpPWpGaD
Busulfan—Decreased appetite—Doxorubicin—breast cancer	4.77e-06	6.48e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—COMT—breast cancer	4.76e-06	0.000102	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTP1—breast cancer	4.74e-06	0.000102	CbGpPWpGaD
Busulfan—Gastrointestinal disorder—Doxorubicin—breast cancer	4.73e-06	6.43e-05	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—breast cancer	4.73e-06	6.43e-05	CcSEcCtD
Busulfan—Urticaria—Epirubicin—breast cancer	4.71e-06	6.4e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—NQO1—breast cancer	4.7e-06	0.000101	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—SLC2A1—breast cancer	4.7e-06	0.000101	CbGpPWpGaD
Busulfan—Pain—Doxorubicin—breast cancer	4.69e-06	6.37e-05	CcSEcCtD
Busulfan—Constipation—Doxorubicin—breast cancer	4.69e-06	6.37e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—GSTT1—breast cancer	4.69e-06	0.000101	CbGpPWpGaD
Busulfan—Abdominal pain—Epirubicin—breast cancer	4.69e-06	6.37e-05	CcSEcCtD
Busulfan—Body temperature increased—Epirubicin—breast cancer	4.69e-06	6.37e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—NOS3—breast cancer	4.67e-06	0.0001	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HMOX1—breast cancer	4.67e-06	0.0001	CbGpPWpGaD
Busulfan—Hypersensitivity—Methotrexate—breast cancer	4.67e-06	6.34e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—ITPR1—breast cancer	4.66e-06	0.0001	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—COMT—breast cancer	4.63e-06	9.96e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTP1—breast cancer	4.61e-06	9.91e-05	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—IL6—breast cancer	4.59e-06	9.87e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP3A4—breast cancer	4.58e-06	9.85e-05	CbGpPWpGaD
Busulfan—Asthenia—Methotrexate—breast cancer	4.54e-06	6.18e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—HMOX1—breast cancer	4.54e-06	9.77e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ITPR1—breast cancer	4.53e-06	9.75e-05	CbGpPWpGaD
Busulfan—Feeling abnormal—Doxorubicin—breast cancer	4.52e-06	6.14e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP1B1—breast cancer	4.5e-06	9.69e-05	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Doxorubicin—breast cancer	4.48e-06	6.09e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—ABCB1—breast cancer	4.48e-06	9.64e-05	CbGpPWpGaD
Busulfan—Pruritus—Methotrexate—breast cancer	4.48e-06	6.09e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP17A1—breast cancer	4.44e-06	9.55e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—HSP90AA1—breast cancer	4.42e-06	9.5e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—TYMS—breast cancer	4.4e-06	9.47e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—PTGS1—breast cancer	4.39e-06	9.45e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	4.38e-06	9.42e-05	CbGpPWpGaD
Busulfan—Hypersensitivity—Epirubicin—breast cancer	4.37e-06	5.93e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—ABCB1—breast cancer	4.36e-06	9.38e-05	CbGpPWpGaD
Busulfan—Urticaria—Doxorubicin—breast cancer	4.36e-06	5.92e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—PLA2G4A—breast cancer	4.35e-06	9.36e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTM1—breast cancer	4.35e-06	9.36e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NCOR1—breast cancer	4.35e-06	9.36e-05	CbGpPWpGaD
Busulfan—Body temperature increased—Doxorubicin—breast cancer	4.34e-06	5.89e-05	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—breast cancer	4.34e-06	5.89e-05	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—breast cancer	4.33e-06	5.89e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—PIK3CB—breast cancer	4.31e-06	9.27e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP2D6—breast cancer	4.31e-06	9.27e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NCOA1—breast cancer	4.3e-06	9.24e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—TYMS—breast cancer	4.28e-06	9.21e-05	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PTGS2—breast cancer	4.27e-06	9.19e-05	CbGpPWpGaD
Busulfan—Asthenia—Epirubicin—breast cancer	4.25e-06	5.78e-05	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	4.25e-06	9.14e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—STK11—breast cancer	4.23e-06	9.11e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NCOR1—breast cancer	4.23e-06	9.11e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP19A1—breast cancer	4.23e-06	9.11e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PLA2G4A—breast cancer	4.23e-06	9.11e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NCOA2—breast cancer	4.23e-06	9.1e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CD—breast cancer	4.21e-06	9.05e-05	CbGpPWpGaD
Busulfan—Pruritus—Epirubicin—breast cancer	4.19e-06	5.7e-05	CcSEcCtD
Busulfan—Dizziness—Methotrexate—breast cancer	4.19e-06	5.69e-05	CcSEcCtD
Busulfan—GSTA2—Metabolism—GPX1—breast cancer	4.17e-06	8.96e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ALB—breast cancer	4.15e-06	8.93e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP1A1—breast cancer	4.13e-06	8.87e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ERCC2—breast cancer	4.09e-06	8.8e-05	CbGpPWpGaD
Busulfan—Diarrhoea—Epirubicin—breast cancer	4.06e-06	5.51e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—GPX1—breast cancer	4.05e-06	8.72e-05	CbGpPWpGaD
Busulfan—Hypersensitivity—Doxorubicin—breast cancer	4.04e-06	5.49e-05	CcSEcCtD
Busulfan—Vomiting—Methotrexate—breast cancer	4.03e-06	5.47e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—CYP1A1—breast cancer	4.01e-06	8.63e-05	CbGpPWpGaD
Busulfan—Rash—Methotrexate—breast cancer	3.99e-06	5.43e-05	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—breast cancer	3.99e-06	5.42e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—ERCC2—breast cancer	3.98e-06	8.56e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—NOS3—breast cancer	3.97e-06	8.54e-05	CbGpPWpGaD
Busulfan—Headache—Methotrexate—breast cancer	3.97e-06	5.39e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—COMT—breast cancer	3.94e-06	8.47e-05	CbGpPWpGaD
Busulfan—Asthenia—Doxorubicin—breast cancer	3.93e-06	5.35e-05	CcSEcCtD
Busulfan—Dizziness—Epirubicin—breast cancer	3.92e-06	5.33e-05	CcSEcCtD
Busulfan—Pruritus—Doxorubicin—breast cancer	3.88e-06	5.27e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—HMOX1—breast cancer	3.86e-06	8.31e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ITPR1—breast cancer	3.85e-06	8.29e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—MTHFR—breast cancer	3.85e-06	8.27e-05	CbGpPWpGaD
Busulfan—Vomiting—Epirubicin—breast cancer	3.77e-06	5.12e-05	CcSEcCtD
Busulfan—Nausea—Methotrexate—breast cancer	3.76e-06	5.11e-05	CcSEcCtD
Busulfan—Diarrhoea—Doxorubicin—breast cancer	3.75e-06	5.1e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—MTHFR—breast cancer	3.74e-06	8.05e-05	CbGpPWpGaD
Busulfan—Rash—Epirubicin—breast cancer	3.74e-06	5.08e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP1B1—breast cancer	3.74e-06	8.04e-05	CbGpPWpGaD
Busulfan—Dermatitis—Epirubicin—breast cancer	3.73e-06	5.07e-05	CcSEcCtD
Busulfan—MGST2—Metabolism—PTEN—breast cancer	3.73e-06	8.01e-05	CbGpPWpGaD
Busulfan—Headache—Epirubicin—breast cancer	3.71e-06	5.05e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—ABCB1—breast cancer	3.71e-06	7.98e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	3.68e-06	7.93e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CB—breast cancer	3.67e-06	7.88e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—TYMS—breast cancer	3.64e-06	7.83e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTGS2—breast cancer	3.63e-06	7.81e-05	CbGpPWpGaD
Busulfan—Dizziness—Doxorubicin—breast cancer	3.63e-06	4.93e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—NCOR1—breast cancer	3.6e-06	7.74e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTM1—breast cancer	3.6e-06	7.74e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PLA2G4A—breast cancer	3.6e-06	7.74e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NCOA1—breast cancer	3.56e-06	7.67e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CAV1—breast cancer	3.55e-06	7.63e-05	CbGpPWpGaD
Busulfan—Nausea—Epirubicin—breast cancer	3.52e-06	4.78e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—CYP19A1—breast cancer	3.51e-06	7.56e-05	CbGpPWpGaD
Busulfan—Vomiting—Doxorubicin—breast cancer	3.49e-06	4.74e-05	CcSEcCtD
Busulfan—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	3.46e-06	7.45e-05	CbGpPWpGaD
Busulfan—Rash—Doxorubicin—breast cancer	3.46e-06	4.7e-05	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—breast cancer	3.45e-06	4.69e-05	CcSEcCtD
Busulfan—GSTM1—Metabolism—CAV1—breast cancer	3.45e-06	7.42e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GPX1—breast cancer	3.45e-06	7.41e-05	CbGpPWpGaD
Busulfan—Headache—Doxorubicin—breast cancer	3.44e-06	4.67e-05	CcSEcCtD
Busulfan—GSTP1—Metabolism—CYP1A1—breast cancer	3.41e-06	7.34e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ERCC2—breast cancer	3.38e-06	7.28e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—COMT—breast cancer	3.27e-06	7.02e-05	CbGpPWpGaD
Busulfan—Nausea—Doxorubicin—breast cancer	3.26e-06	4.43e-05	CcSEcCtD
Busulfan—CYP3A4—Biological oxidations—GSTP1—breast cancer	3.25e-06	6.99e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CG—breast cancer	3.23e-06	6.95e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—COMT—breast cancer	3.22e-06	6.93e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	3.21e-06	6.89e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—MTHFR—breast cancer	3.18e-06	6.84e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PTEN—breast cancer	3.17e-06	6.81e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CG—breast cancer	3.14e-06	6.76e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.99e-06	6.42e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.95e-06	6.34e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CAV1—breast cancer	2.93e-06	6.31e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CD—breast cancer	2.84e-06	6.11e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.83e-06	6.09e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALB—breast cancer	2.8e-06	6.03e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.79e-06	6.01e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CD—breast cancer	2.76e-06	5.94e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALB—breast cancer	2.73e-06	5.87e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NOS3—breast cancer	2.68e-06	5.77e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CG—breast cancer	2.67e-06	5.75e-05	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—breast cancer	2.63e-06	5.65e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NOS3—breast cancer	2.61e-06	5.61e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CB—breast cancer	2.48e-06	5.33e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTGS2—breast cancer	2.45e-06	5.28e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CB—breast cancer	2.41e-06	5.18e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTGS2—breast cancer	2.39e-06	5.13e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CD—breast cancer	2.35e-06	5.05e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALB—breast cancer	2.32e-06	4.99e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SYNJ2—breast cancer	2.28e-06	4.9e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—breast cancer	2.23e-06	4.81e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NOS3—breast cancer	2.22e-06	4.77e-05	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKT1—breast cancer	2.15e-06	4.62e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PTEN—breast cancer	2.14e-06	4.6e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NDUFS3—breast cancer	2.12e-06	4.55e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PTEN—breast cancer	2.08e-06	4.48e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CB—breast cancer	2.05e-06	4.41e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTGS2—breast cancer	2.03e-06	4.37e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CHST9—breast cancer	1.99e-06	4.28e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—COX11—breast cancer	1.89e-06	4.06e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKT1—breast cancer	1.83e-06	3.93e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PTEN—breast cancer	1.77e-06	3.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SHMT1—breast cancer	1.73e-06	3.71e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CDA—breast cancer	1.73e-06	3.71e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.66e-06	3.57e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC2A5—breast cancer	1.66e-06	3.57e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—APRT—breast cancer	1.6e-06	3.45e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—breast cancer	1.51e-06	3.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ESRRA—breast cancer	1.51e-06	3.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.51e-06	3.25e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—breast cancer	1.47e-06	3.16e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPI—breast cancer	1.43e-06	3.08e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HADHB—breast cancer	1.43e-06	3.08e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.36e-06	2.94e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.36e-06	2.94e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PHGDH—breast cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—FHL2—breast cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ADSL—breast cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—UMPS—breast cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NME1—breast cancer	1.31e-06	2.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HPSE—breast cancer	1.28e-06	2.76e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—BRIP1—breast cancer	1.28e-06	2.76e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—LDHB—breast cancer	1.28e-06	2.76e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—breast cancer	1.25e-06	2.69e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—AKT1—breast cancer	1.23e-06	2.65e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HMMR—breast cancer	1.22e-06	2.62e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCC1—breast cancer	1.22e-06	2.62e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA3—breast cancer	1.22e-06	2.62e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKT1—breast cancer	1.2e-06	2.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.18e-06	2.53e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA4—breast cancer	1.11e-06	2.39e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CA9—breast cancer	1.11e-06	2.39e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA2—breast cancer	1.08e-06	2.33e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPX2—breast cancer	1.08e-06	2.33e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPX4—breast cancer	1.07e-06	2.3e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SULT1A1—breast cancer	1.07e-06	2.3e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—IDH1—breast cancer	1.05e-06	2.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA1—breast cancer	1.05e-06	2.25e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NAT2—breast cancer	1.03e-06	2.22e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—AKT1—breast cancer	1.02e-06	2.19e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—DPYD—breast cancer	9.07e-07	1.95e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MED12—breast cancer	9.07e-07	1.95e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDOA—breast cancer	8.93e-07	1.92e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NCOA3—breast cancer	8.67e-07	1.86e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC2A2—breast cancer	8.6e-07	1.85e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCG2—breast cancer	8.43e-07	1.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CPT1A—breast cancer	8.43e-07	1.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MTR—breast cancer	8.43e-07	1.81e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HPGDS—breast cancer	8.27e-07	1.78e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HBA1—breast cancer	8.21e-07	1.77e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTT1—breast cancer	8.02e-07	1.72e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ACHE—breast cancer	8.02e-07	1.72e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP17A1—breast cancer	7.59e-07	1.63e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS1—breast cancer	7.51e-07	1.62e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ENO1—breast cancer	7.51e-07	1.62e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP2D6—breast cancer	7.37e-07	1.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NCOA2—breast cancer	7.23e-07	1.56e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—FASN—breast cancer	7.01e-07	1.51e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—BCHE—breast cancer	6.98e-07	1.5e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC5A5—breast cancer	6.9e-07	1.48e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—SLC2A1—breast cancer	6.66e-07	1.43e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NQO1—breast cancer	6.66e-07	1.43e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP1B1—breast cancer	6.39e-07	1.37e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HSP90AA1—breast cancer	6.27e-07	1.35e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NCOA1—breast cancer	6.09e-07	1.31e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—STK11—breast cancer	6.01e-07	1.29e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP19A1—breast cancer	6.01e-07	1.29e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—COMT—breast cancer	5.58e-07	1.2e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTP1—breast cancer	5.56e-07	1.2e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HMOX1—breast cancer	5.48e-07	1.18e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ITPR1—breast cancer	5.47e-07	1.18e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ABCB1—breast cancer	5.26e-07	1.13e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TYMS—breast cancer	5.17e-07	1.11e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTM1—breast cancer	5.11e-07	1.1e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PLA2G4A—breast cancer	5.11e-07	1.1e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NCOR1—breast cancer	5.11e-07	1.1e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GPX1—breast cancer	4.89e-07	1.05e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP1A1—breast cancer	4.84e-07	1.04e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ERCC2—breast cancer	4.8e-07	1.03e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MTHFR—breast cancer	4.51e-07	9.71e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CAV1—breast cancer	4.16e-07	8.96e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CG—breast cancer	3.79e-07	8.16e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CD—breast cancer	3.33e-07	7.17e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALB—breast cancer	3.29e-07	7.08e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NOS3—breast cancer	3.15e-07	6.77e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CB—breast cancer	2.91e-07	6.25e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTGS2—breast cancer	2.88e-07	6.19e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PTEN—breast cancer	2.51e-07	5.4e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—breast cancer	1.77e-07	3.81e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKT1—breast cancer	1.45e-07	3.11e-06	CbGpPWpGaD
